Parallax Volatility Advisers, L.P. Theravance Biopharma, Inc. Put Options Transaction History

Parallax Volatility Advisers, L.P.

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2021 Feb 14, 2022	SELL	$7.42 - $11.05 $2.63 Million - $3.91 Million	-354,000 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$6.77 - $14.41 $311,420 - $662,860	-46,000 Reduced 11.5%	354,000 $2.62 Million
Q2 2019 Aug 14, 2019	BUY	$15.6 - $25.15 $3.12 Million - $5.03 Million	200,000 Added 100.0%	400,000 $6.53 Million
Q1 2019 May 15, 2019	BUY	$22.57 - $28.15 $4.51 Million - $5.63 Million	200,000 New	200,000 $4.53 Million

129

46.5M

600

300

Ticker TBPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,782,400
Market Cap $622M
Description
Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.